Integration of NAVOY® Sepsis in an Electronic Health Record System
NCT ID: NCT05095220
Last Updated: 2023-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2022-05-27
2023-03-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning
NCT05893420
Prediction of 30-Day Readmission Using Machine Learning
NCT04849312
Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient
NCT04412031
Machine Learning-based Early Clinical Warning of High-risk Patients
NCT05410171
Novel Non-Invasive Monitoring Parameter in a Hospital Setting
NCT01306201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject is 18 years of age or older at the time of admission to the ICU.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AlgoDx
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Arlbrandt, MD
Role: PRINCIPAL_INVESTIGATOR
Southern General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southern General Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SEP-SE-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.